MORGAN STANLEY PLC/CALL/REVVITY/100/0.1/21.03.25 Stock

Warrant

DE000MG3SA28

Market Closed - Börse Stuttgart 14:22:38 2024-06-14 EDT
1.84 EUR -2.65% Intraday chart for MORGAN STANLEY PLC/CALL/REVVITY/100/0.1/21.03.25
Current month+8.88%
1 month+15.72%
Date Price Change
24-06-14 1.84 -2.65%
24-06-13 1.89 -3.08%
24-06-12 1.95 +8.94%
24-06-11 1.79 +0.56%
24-06-10 1.78 -3.78%

Delayed Quote Börse Stuttgart

Last update June 14, 2024 at 02:22 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying REVVITY, INC.
Issuer Morgan Stanley
WKN MG3SA2
ISINDE000MG3SA28
Date issued 2024-05-07
Strike 100 $
Maturity 2025-03-21 (278 Days)
Parity 10 : 1
Emission price 1.47
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 2
Lowest since issue 1.38
Delta0.71x
Omega 3.890
Premium10.27x
Gearing5.49x
Moneyness 1.087
Difference Strike -8.65 $
Difference Strike %-8.65%
Spread 0.14
Spread %7.29%
Theoretical value 1.850
Implied Volatility 35.22 %
Total Loss Probability 40.26 %
Intrinsic value 0.8079
Present value 1.042
Break even 119.81 €
Theta-0.02x
Vega0.03x
Rho0.04x

Company Profile

Revvity, Inc. (formerly PerkinElmer, Inc.) specializes in designing, manufacturing, and marketing measurement devices and analytical instruments for the healthcare, environmental, scientific research, industry and food sectors. Net sales (including intragroup) break down by family of products as follows: - medical diagnosis equipment (61%); - analytical tools and instruments (39%): biological molecular research tools, thermal analysis software, chemical and environmental measurement tools, genetic screening instruments, reagents, etc. Net sales are distributed geographically as follows: the United States (46.7%), China (14.4%), the United Kingdom (4.1%) and other (34.8%).
Sector
-
More about the company

Ratings for Revvity, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: Revvity, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
108.6 USD
Average target price
124.1 USD
Spread / Average Target
+14.22%
Consensus